Down-regulation of tumor suppressor PDCD4 expression in endometrium of adenomyosis patients
article
OA: closed
CC0
⤵ 6 in-corpus citations
AI-generated summary
This study investigated the expression of tumor suppressor PDCD4 in the endometrium of adenomyosis patients and found that its expression was down-regulated.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveAdenomyosis is a common benign gynecological disease which has some malignant behaviors. Programmed cell death 4 (PDCD4) is a newly identified tumor suppressor gene which lowly expresses in various cancers. However, the expression status of PDCD4 in endometrium of adenomyosis patients has not been investigated. The aim of this study is to assess the expression levels of PDCD4 in endometrium of normal controls and adenomyosis patients.MethodsThe expression of PDCD4 in endometrium of normal controls and eutopic or ectopic endometrium of patients with adenomyosis was evaluated with quantitative real-time PCR, western blot and immunohistochemistry. In addition, the levels of serum estradiol and progesterone in normal controls and adenomyosis patients were detected using electrochemiluminescence immunoassay.ResultsThe results showed that PDCD4 mainly expressed in the cytoplasma of glandular epithelium of control endometrium and varied during the cycle changes of endometrium, which may be regulated by changing concentrations of progesterone in the menstrual cycle. Compared with the proliferative phase of control endometrium, PDCD4 expression was down-regulated in proliferative phase of eutopic endometrium or ectopic endometrium, and there was no cyclic variation of PDCD4 expression in eutopic endometrium of adenomyosis patients due to progesterone resistance.ConclusionThese results suggest that PDCD4 may be involved in the pathogenesis of adenomyosis, which will provide a novel strategy for the early diagnosis and new therapeutic target of adenomyosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (35)
- Adenomyosis at hysterectomy: prevalence and relationship to operative findings and reproductive and menstrual factors. via openalex
- Adenomyosis: Review of the Literature via openalex
- Clinical significance of adenomyosis. via openalex
- Endometrial-Myometrial Interface: Relationship to Adenomyosis and Changes in Pregnancy via openalex
- Experimental adenomyosis via openalex
- Expression and possible role of interleukin-10 receptors in patients with adenomyosis via openalex
- L-22 enhances the invasiveness of endometrial stromal cells of adenomyosis in an autocrine manner. via openalex
- Mechanisms of endometrial progesterone resistance via openalex
- The expression and functionality of stromal caveolin 1 in human adenomyosis via openalex
- W2042812307 via openalex
- W2059968407 via openalex
- W2067617459 via openalex
- W2069932990 via openalex
- W2071878775 via openalex
- W2081438743 via openalex
- W2081476178 via openalex
- W2104052951 via openalex
- W2115619054 via openalex
- W2121306814 via openalex
- W2134604398 via openalex
- W2151886488 via openalex
- W2165371985 via openalex
- W2265658450 via openalex
- W6692974097 via openalex
- W6703470536 via openalex
- W1966417898 via openalex
- W6712010351 via openalex
- W1970111367 via openalex
- W1986424797 via openalex
- W1995291683 via openalex
- W1998639716 via openalex
- W2027696262 via openalex
- W2038354928 via openalex
- W2038623184 via openalex
- W2041824736 via openalex
Cited by (6)
- Epigenomic Analysis Reveals the KCNK9 Potassium Channel as a Potential Therapeutic Target for Adenomyosis 2022
- The Pathogenesis of Adenomyosis 2021
- Interaction of M2 macrophages and endometrial cells induces downregulation of GRIM-19 in endometria of adenomyosis 2020
- Bioinformatics strategy for the screening of key genes to differentiate adenomyosis from endometriosis (Review) 2019
- A new trick for an old dog: The application of mifepristone in the treatment of adenomyosis 2019
- PDCD4 suppresses proliferation, migration, and invasion of endometrial cells by inhibiting autophagy and NF-κB/MMP2/MMP9 signal pathway† 2018
Source provenance
- europepmc
- last seen: 2026-08-17T06:11:01.428247+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:49.724109+00:00
- unpaywall
- last seen: 2026-08-17T06:25:09.426038+00:00
License: CC0
· commercial use OK